Registration - In-house Corporation

Pharmascience Inc. / David Goodman, Chief Executive Officer

Registration Information

In-house Corporation name: Pharmascience Inc.
Responsible Officer Name: David Goodman, Chief Executive Officer
Responsible Officer Change History
Initial registration start date: 2009-02-02
Registration status: Active
Registration Number: 725814-234102

Associated Communications

Total Number of Communication Reports: 56

Monthly communication reports in the last 6 months: 1

Version 7 of 30 (2013-05-27 to 2014-02-27)

Registration versions:

Version 7 of 30 (2013-05-27 to 2014-02-27)

Lobbying Information

Subject Matters

Economic Development
Health
Industry
Intellectual Property
International Development
International Trade
Regional Development
Science and Technology

Subject Matter Details

Legislative Proposal, Bill or Resolution

Health Canada regarding the modernization of the Food and Drug Act (formerly Bill C-51) with respect to the development and implementation of a Progressive Licensing Framework for pharmaceuticals.
Industry Canada regarding export provisions of the Patent Act (pharmaceuticals)
Industry Canada with respect to the Patent Act as it pertains to pharmaceuticals.
Provide input into the Government of Canada's negotiations regarding the Canada-European Union Comprehensive Economic and Trade Agreement (CETA) with respect to pharmaceuticals, counterfeit medicines, border measures and intellectual property

Policies or Program

Health Canada regarding the development and implementation of an approval pathway for Subsequent Entry Biologics (SEBs)
Health Canada regarding the need for appropriate, dedicated resources for the Therapeutic Product Directorate to meet performance targets for the review of generic drug submissions.
Health Canada, Industry Canada and International Trade to address fundamental flaws with respect to Canada's Access to Medicines Regimes
Health Canada, Industry Canada, and International Trade Canada regarding effective measures to combat counterfeit drugs in Canada and around the world.
Industry Canada's science and Technology strategy regarding the need for a balanced Intellectual Property regime and the important role competition plays in encouraging innovation.

Regulation

Canadian Generic Pharmaceutical Association's ("CGPA") legal challenge of the 2006 Amendments to Health Canada's Food and Drug Regulations with respect to Data Exclusivity.
Industry Canada regarding the need to restore balance to the Patented Medicines (Notice of Compliance) Regulations with respect to pharmaceuticals and address operational concerns including: lack of finality to proceedings under the Regulations and lack of disincentives to discourage abuse of the Regulations.

Communication Techniques

Written communication
Oral communication
Grass-roots communication

Government Institutions

Canada Revenue Agency (CRA)
Canadian Heritage (PCH)
Canadian Institutes of Health Research (CIHR)
Canadian International Development Agency (CIDA)
Canadian International Trade Tribunal (CITT)
Competition Tribunal (CT)
Finance Canada (FIN)
Foreign Affairs and International Trade Canada (DFAITC)
Health Canada (HC)
Industry Canada
Justice Canada (JC)
Patented Medicine Prices Review Board (PMPRB)
Solicitor General Canada (SGC)
Treasury Board Of Canada Secretariat (TBS)

In-house Corporation Details

Description of activities

Pharmascience Inc. is a Canadian-owned pharmaceutical company specializing in the manufacturing and distribution of generic, innovative, and consumer brand pharmaceutical products in Canada

Responsible officer name and position during the period of this registration

David Goodman, Chief Executive Officer

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
6111 Royalmount avenue, suite 100
Montreal, QC H4P 2T4
Canada

Telephone number: 514-340-9800
Fax number: 514-342-3654

Parent Company Information

Joddes Limited
- 6111 Royalmount Avenue, suite 100
  Montreal, QC H4P 2T4
  Canada

Subsidiary Beneficiary Information

Pharmascience Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Pierre Gaudreault, General Manager, Pharmascience Canada | No public offices held
David Goodman, Chief Executive Officer | No public offices held
Morris Goodman, Chairman of the Board of Directors | No public offices held
Larry MacGirr, President and COO | No public offices held
Leonard Neirinck, Senior Vice President Scientific Affairs | No public offices held
Josée Thérien, Director, Market Access | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

No lobbyists added

Pharmascience Inc.

The following names have been used on or after July 2, 2008

Name	From	To
Pharmascience Inc.	2009-02-02	current

Pharmascience Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
David Goodman	2025-02-17	Current
Martin Arès	2023-01-03	2025-02-17
David Goodman	2009-02-02	2023-01-03

Date Modified:: 2025-06-03

Search and menus

Language selection

Registration - In-house Corporation

Pharmascience Inc. / David Goodman, Chief Executive Officer

Registration Information

Associated Communications

Version 7 of 30 (2013-05-27 to 2014-02-27)

Version 7 of 30 (2013-05-27 to 2014-02-27)

Subject Matters

Subject Matter Details

Legislative Proposal, Bill or Resolution

Policies or Program

Regulation

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties